Invests in categories: AIBioTechDataHealthTechInformationLegalTechNewsPlatformSoftwareTechnology
Cambridge Innovation Capital is a leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies. CIC currently manages over £275 million and has invested in 30+ companies.
CIC is also a preferred investor for the University of Cambridge, Europe’s top source of founders for venture-backed start-ups.
For more information visit www.cic.vc or follow @CambsInnovation
CIC is also a preferred investor for the University of Cambridge, Europe’s top source of founders for venture-backed start-ups.
For more information visit www.cic.vc or follow @CambsInnovation
News
678
Portfolio
44
Mentions
86
Location: United Kingdom, England, Cambridge
Employees: 51-200
Founded date: 2013
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B
Portfolio 44
| Date | Name | Website | Total Raised | Location |
| 21.04.2026 | Companies | immutrin.com | - | - |
| 21.04.2026 | Companies | trent.ai | $13M | United Kin... |
| 25.02.2026 | BeyondMath | beyondmath.com | $27M | United Kin... |
| 30.05.2025 | Trimtech T... | trimtechtherapeutics.com | $78M | - |
| 30.05.2025 | Companies | sortera.bio | - | - |
| 26.12.2024 | Nuclera | nuclera.com | $262.04M | United Kin... |
| 26.12.2024 | Forefront ... | forefrontrf.com | $31.24M | - |
| 18.05.2023 | Secondmind | secondmind.ai | $16M | United Kin... |
| 18.05.2023 | AudioTelli... | audiotelligence.com | $12.54M | United Kin... |
| 18.05.2023 | Audio Anal... | audioanalytic.com | $17.5M | United Kin... |
| 18.05.2023 | Predict Im... | predictimmune.com | $25.2M | United Kin... |
| 18.05.2023 | Exvastat | exvastat.com | - | United Kin... |
| 18.05.2023 | Storm Ther... | stormtherapeutics.com | $145.62M | United Kin... |
| 18.05.2023 | Inivata | inivata.com | $139.35M | United Sta... |
| 18.05.2023 | Carrick Th... | carricktherapeutics.com | $137.97M | United Sta... |
| 18.05.2023 | Microbioti... | microbiotica.com | $67M | United Kin... |
| 18.05.2023 | Centessa P... | centessa.com | $250M | United Kin... |
| 18.05.2023 | T-Therapeu... | t-therapeutics.com | $150.63M | United Kin... |
| 18.05.2023 | CMR Surgic... | cmrsurgical.com | $1.36B | United Kin... |
| 18.05.2023 | Cytora | cytora.com | $43.07M | United Kin... |
| 18.05.2023 | Riverlane | riverlane.com | $233.78M | United Kin... |
| 18.05.2023 | Sense Biod... | sense-bio.com | $80.83M | United Kin... |
| 18.05.2023 | Imagen | imagen.io | $8.53M | United Kin... |
| 18.05.2023 | Gyroscope ... | gyroscopetx.com | $423.34M | United Kin... |
| 18.05.2023 | Origami | origamienergy.com | $104.93M | United Kin... |
| 18.05.2023 | Seldon | seldon.io | $32.92M | United Kin... |
| 18.05.2023 | Companies | petmedix.com | - | - |
| 18.05.2023 | PragmatIC | pragmaticsemi.com | $527.14M | United Kin... |
| 18.05.2023 | Congenica | congenica.com | $167M | United Kin... |
| 18.04.2023 | Complement... | complementtx.com | $84.66M | United Kin... |
| 06.04.2023 | Mosaic TX | mosaic-tx.com | - | United Kin... |
| 11.03.2023 | Nstream | nstream.io | - | United Sta... |
| 21.11.2022 | Cambridge ... | camgandevices.com | $92.5M | United Kin... |
| 20.10.2022 | Unlikely A... | unlikely.ai | $20M | United Kin... |
| 20.10.2022 | GENinCode | genincode.com | $4.49M | United Kin... |
| 18.05.2022 | Salience L... | saliencelabs.ai | $41.5M | United Kin... |
| 17.11.2021 | Epitopea | epitopea.com | $45.65M | United Kin... |
| 09.11.2021 | Pretzel Th... | pretzeltx.com | $72.5M | United Sta... |
| - | Abcodia | abcodia.com | $9.85M | United Kin... |
| - | PolyProx T... | polyprox.com | $5.71M | - |
| - | Swim | swim.ai | $10M | United Sta... |
| - | Fluidic An... | fluidic.com | $31M | United Kin... |
| - | GeoSpock | geospock.com | $61.77M | United Kin... |
| - | Undo | undo.io | $54.36M | United Kin... |
Show more
News 678
| Date | Title | Description |
| 27.04.2023 | Complement Therapeutics appoints Dominic Moreland as Chief Financial Officer | Complement Therapeutics appoints Dominic Moreland as Chief Financial Officer Complement Therapeutics GmbH, a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases, today announced the appoint... |
| 24.04.2023 | Riverlane raises £15m Series B to advance useful quantum computing | Riverlane raises £15m Series B to advance useful quantum computing Quantum engineering company Riverlane today announced it has raised £15 million in a Series B funding. The round was led by Molten Ventures and included participation from s... |
| 17.04.2023 | Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding | Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has ... |
| 17.04.2023 | VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year | VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year Endpoints News | By Kyle LaHucik, Associate Editor Complement Therapeutics raised a €72 million ($79.6 million) Series A to bankroll a Phase Ib of its ... |
| 17.04.2023 | Complement Therapeutics closes $79M A round for gene therapy in geographic atrophy | Complement Therapeutics closes $79M A round for gene therapy in geographic atrophy BioWorld | By Cormac Sheridan Complement Therapeutics GmbH raised €72 million (US$79.4 million) in a series A round to move into the clinic a novel gene ther... |
| 12.04.2023 | Microbiotica announces collaboration with MSD in a Phase 1b Clinical Trial in melanoma | Microbiotica announces clinical trial collaboration with MSD to evaluate MB097 in combination with KEYTRUDA® (pembrolizumab) in a Phase 1b Clinical Trial in melanoma Microbiotica, a leader in discovering and developing microbiome-based ther... |
| 12.04.2023 | Pragmatic Semiconductor announces appointment of semiconductor industry veteran, David Moore, as CEO | Pragmatic Semiconductor announced today that its Board of Directors has appointed semiconductor industry veteran, David Moore, as Chief Executive Officer Moore will join Pragmatic with immediate effect and takes over from Pragmatic’s co-Fou... |
| 07.04.2023 | UK’s Cambridge tries to catch up with younger, innovative peer | UK’s Cambridge tries to catch up with younger, innovative peer New initiative aims to promote UK city on the world stage Kendall Square in Massachusetts is seen as a model for the UK Bloomberg UK | By Lisa Pham Home to one of the world’s ol... |
| 05.04.2023 | We celebrate 10 years of ‘Science WOW’ | We celebrate 10 years of ‘Science WOW’ For the past ten years, Cambridge Science Centre has inspired over 500,000 children and young people with immersive STEM experiences and mind-blowing events. To kick off the festivities, Cambridge Scie... |
| 04.04.2023 | Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding | Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in ... |
| 04.04.2023 | Oncology startup from Sanger Institute nabs $28M, ex-Novartis SVP as CEO | Oncology startup from Sanger Institute nabs $28M, ex-Novartis SVP as CEO Endpoints | Kyle LaHucik, Associate Editor The Wellcome Sanger Institute’s latest oncology spinout will enter the clinic in about 18 to 24 months with a new CEO at the... |
| 28.03.2023 | AudioTelligence announces Orsana, the first universal assistive listening device | AudioTelligence announces Orsana, the first universal assistive listening device By AudioTelligence Orsana is the first universal assistive listening device designed to help everyone hear clearly in noise - with or without hearing aids. In ... |
| 28.03.2023 | Bicycle Therapeutics announces a strategic collaboration with Novartis to discover, develop and commercialize Bicycle® Radio-Conjugates | Bicycle Therapeutics announces a strategic collaboration with Novartis to discover, develop and commercialize Bicycle® Radio-Conjugates Bicycle and Novartis will collaborate on the discovery and development of multiple targeted radioligand ... |
| 27.03.2023 | Ruggedness of Cambridge GaN Devices’ ICeGaN Technology Proven in Virginia Tech Paper at APEC | Ruggedness of Cambridge GaN Devices’ ICeGaN Technology Proven in Virginia Tech Paper at APEC >70 V over-voltage capability combines with intelligent on-chip protection to deliver highest GaN reliability and ruggedness Cambridge GaN Devic... |
| 24.03.2023 | Riverlane-led research shows how quantum computers may simulate materials to reduce humanity’s impact on the environment | Riverlane-led research shows how quantum computers may simulate materials to reduce humanity’s impact on the environment The Quantum Insider | By Matt Swayne Insider Brief Researchers say quantum algorithms could simulate the catalysts used... |
| 21.03.2023 | CIPA East of England Meeting 2023 | CIPA East of England Meeting 2023 Venue: The Clayton Hotel, Station Road, Cambridge Innovation is the lifeblood of society. Ingenious inventions, fresh product designs, iconic brands and artistic creativity are not only the building blocks ... |
| 20.03.2023 | Cambridge University’s economic impact | Cambridge University’s economic impact The University contributes nearly £30 billion to the UK economy and supports more than 86,000 jobs across the UK. A report by London Economics has measured the University of Cambridge’s impact on the U... |
| 20.03.2023 | Cambridge’s blueprint points the way for UK investment zones | Cambridge’s blueprint points the way for UK investment zones With the right policies in place, the university can repeat the past 25 years’ economic return within the next decade, says Anthony Freeling Times Higher Education | By Anthony Fr... |
| 20.03.2023 | Almost 90,000 jobs and £30bn for the economy due to Cambridge University | Almost 90,000 jobs and £30bn for the economy due to Cambridge University Business Weekly | By Tony Quested The University of Cambridge has contributed almost £30 billion to the UK economy and supports nearly 90,000 jobs across the country, ... |
| 16.03.2023 | Seeking Cambridge’s Science and Technology pathfinders | Seeking Cambridge’s Science and Technology pathfinders Business Weekly article One of the most significant and exciting developments in the Cambridge Cluster in recent times has been a surge of exploration by collaborating companies at the ... |
| 16.03.2023 | MLOps platform Seldon raises $20M Series B to improve the productions of AI models | MLOps platform Seldon raises $20M Series B to improve the productions of AI models TechCrunch | By Mike Butcher The rise of ChatGPT has fuelled growth in the public awareness of AI, as well as the growing discourse around AI ethics. How sho... |
| 15.03.2023 | CMR Surgical appoints new leader | CMR Surgical appoints new leader CMR Surgical announces Supratim Bose as Chief Executive Officer CMR Surgical (‘CMR’ or the ‘Company’) – the global surgical robotics company, today announces that Supratim Bose has become Chief Executive Off... |
| 15.03.2023 | Quantum community reacts to UK’s £2.5 Billion plan for quantum | Quantum community reacts to UK’s £2.5 Billion plan for quantum By Matt Swayne | The Quantum Insider Computing Business The UK budget will include an approximate £2.5 billion investment in quantum technologies, dubbed “The Plan for Quantum,”... |
| 14.03.2023 | How do you teach a computer to smell? | How do you teach a computer to smell? By Emre Ozer | Pragmatic Emre Ozer, Pragmatic’s Senior Director, Processor Development, discusses the development of the world’s first e-nose sensor system on flexible substrate A friend buys you a bunc... |
| 13.03.2023 | In BloombergUK's morning briefing, Steve Brierly spoke about Riverlane's journey from a Cambridge university spin-out to expansion into the US | In BloombergUK's morning briefing, Founder & CEO Steve Brierley spoke to Caroline Hepker about the Impulse Maxwell programme and Riverlane's journey from a Cambridge university spin-out to expansion into the US Listen to the podcast On ... |
| 09.03.2023 | UK microchip firms ask government for hundreds of millions | UK microchip firms ask government for hundreds of millions BBC article | By By Jonty Bloom and Will Smale Business reporters The boss of one of the UK's leading microchip firms is calling for the government to invest "hundreds of milli... |
| 09.03.2023 | University and investor experts to head up review of UK spin-out landscape | University and investor experts to head up review of UK spin-out landscape Experts appointed to identify best practice in turning university research into commercial success HM Treasury press release Professor Irene Tracey CBE and Dr Andrew... |
| 03.03.2023 | CISL Sustainability Essentials for your SMEs/Start-ups | CISL Sustainability Essentials for your SMEs/Start-ups 2-3 March 2023 | The Entopia Building, 1 Regent Street, Cambridge, CB2 1GG About Join this programme to gain insights into the practical steps your business can take to improve your sus... |
| 28.02.2023 | Bicycle Therapeutics reports fourth quarter and full year 2022 financial Results and provides corporate update | Bicycle Therapeutics reports fourth quarter and full year 2022 financial Results and provides corporate update Significant progress across pipeline including advancing BT8009, BT5528, and BT7480 in ongoing clinical trials BT8009 granted Fas... |
| 25.02.2023 | Mantra Or Reality: What Do Britain’s Scaleups Want From The “Science Superpower” Agenda? | Mantra Or Reality: What Do Britain’s Scaleups Want From The “Science Superpower” Agenda? Forbes | By Trevor Clawson There’s nothing a politician likes better than a mantra - a phrase that can be repeated again and again until, possibly, tho... |
| 21.02.2023 | Listen to UKTN and CGD founder Giorgia Longobardi discuss semiconductor strategy, a green silicon alternative & women in STEM | Semiconductor strategy, a green silicon alternative & women in STEM – Cambridge GaN Devices founder Giorgia Longobardi Dr Giorgia Longobardi, the co-founder and CEO of Cambridge GaN Devices, shares her experience spinning out a startup ... |
| 13.02.2023 | British semiconductor bosses threaten to move overseas as U.S. and EU splurge on chips | British semiconductor bosses threaten to move overseas as U.S. and EU splurge on chips CNBC article | By Ryan Browne KEY POINTS U.K. semiconductor bosses are pleading with the government for subsidies amid fears that some chip firms will be... |
| 12.02.2023 | Robot surgery can cut into NHS waiting lists, say doctors | Robot surgery can cut into NHS waiting lists, say doctors Patients recover quicker, with less scarring and are less likely to be readmitted The Times article | By Kat Lay, Health Editor Adopting robotic surgery could free up thousands of be... |
| 07.02.2023 | British science and technology businesses ask for more Government support to achieve global superpower ambitions | British science and technology businesses ask for more Government support to achieve global superpower ambitions Press release | Pragmatic Semiconductor New research has revealed that while two-thirds (68%) of science and technology busines... |
| 05.02.2023 | Tech unicorns are slain as start-ups enter the dreaded ‘down round’ | Tech unicorns are slain as start-ups enter the dreaded ‘down round’ Start-ups that fetched racy valuations in the boom years are facing a rude awakening, says Jamie Nimmo The Sunday Times | By Jamie Nimmo When former British Army officer Wi... |
| 01.02.2023 | Sense announces agreement to be acquired by Sherlock Biosciences | Sense announces agreement to be acquired by Sherlock Biosciences Companies enhance leadership in molecular diagnostics by pairing Sherlock’s advanced CRISPR, synthetic biology and AI technologies with Sense’s instrument-free diagnostic hard... |
| 31.01.2023 | Seldon and Snorkel AI partner to advance data-centric AI | Seldon and Snorkel AI partner to advance data-centric AI By Tom Davies, VP of Alliances at Seldon This post was co-authored with Snorkel AI’s Head of Partnerships Friea Berg Building a machine learning (ML) pipeline can be a challenging and... |
| 31.01.2023 | Four steps to building a semiconductor industry fit for the future | Four steps to building a semiconductor industry fit for the future Politics Home article | By Scott White, CEO of Pragmatic Semiconductor The UK Government’s much anticipated semiconductor strategy provides an opportunity to seize a leading... |
| 27.01.2023 | Scrip asks...What does 2023 hold for Bioharma? Technological advances | Scrip asks... What does 2023 hold for Bioharma? Part 5: Technological advances Expectations high for precision medicine, artificial intelligence and RNA technologies Scrip article | By Eleanor Malone Executive Summary The confluence of data... |
| 26.01.2023 | HTE MedTech FUTURES Conference | HTE MedTech FUTURES Conference Location: Hinxton Hall Conference Centre, Wellcome Trust Genome Campus, Saffron Walden, CB10 1SAH 9:00 - 16.30 The MedTech FUTURES conference, delivered by Health Tech Enterprise, aims to explore the way techn... |
| 26.01.2023 | Don’t blow Britain’s great life sciences chance | Don’t blow Britain’s great life sciences chance We are fast becoming an innovation hub but lack of investment risks sending best talent abroad The Times article | By Emma Duncan The announcement earlier this month that BioNTech is to trial ... |
| 26.01.2023 | Taking stock - what 2023's policy and finance environment means for biotech | Taking stock - what 2023's policy and finance environment means for biotech 15:30 - 18:45 Pinsent Masons - 30 Crown Place, Earl Street, London, EC2A 4ES Networking Ahead of the BIA Gala Dinner, this event will provide key insight and additi... |
| 24.01.2023 | Pioneering sustainable semiconductor manufacturing | Pioneering sustainable semiconductor manufacturing Addressing the carbon impact of semiconductor manufacturing Electronics is globally one of the world’s most polluting industries. Semiconductors have overtaken the automotive sector in over... |
| 15.01.2023 | Back British microchip factories before it's too late, Rishi Sunak told | Back British microchip factories before it's too late, Rishi Sunak told The Telegraph article | By Gareth Corfield Britain must start reshoring computer chip production before it’s too late, Rishi Sunak has been told. Two of Britain’s pre-e... |
| 09.01.2023 | Scrip asks...What does 2023 hold for biopharma? M&A and Partnering | Scrip asks...What does 2023 hold for biopharma? Part 2: M&A and Partnering Big pharma has cash and biotech needs it Scrip article | By Eleanor Malone Executive Summary Deal-making between big pharma and biotech looks set to rise with a ... |
| 09.01.2023 | Scrip asks...What does 2023 hold for biopharma? Part 2: M&A and Partnering | Scrip asks...What does 2023 hold for biopharma? Part 2: M&A and Partnering Big pharma has cash and biotech needs it Scrip article | By Eleanor Malone Executive Summary Deal-making between big pharma and biotech looks set to rise with a ... |
| 05.01.2023 | United States cancer coup for Bicycle Therapeutics | United States cancer coup for Bicycle Therapeutics Business Weekly article | By Tony Quested The all-powerful FDA in the United States has granted Fast Track Designation (FTD) to Bicycle Therapeutics’ BT8009 monotherapy for the treatment of... |
| 03.01.2023 | Cambridge tops UK’s ‘New Economy’ thrust | Cambridge tops UK’s ‘New Economy’ thrust Cambridge’s status as a world-class Science & Technology hub has been further underlined by a recent Centre for Cities report. Business Weekly article | By Tony Quested The study shows Cambridge ... |
| 03.01.2023 | The year of the surgical robot: What’s in store for 2023 | The year of the surgical robot: What’s in store for 2023 By CMR Surgical The last few years have seen an acceleration in the use of surgical robotics. It has been an exciting period for the surgical teams launching and expanding their robot... |
| 19.12.2022 | Carrick Therapeutics and the Menarini Group announce clinical trial collaboration | Carrick Therapeutics and the Menarini Group announce clinical trial collaboration to evaluate samuraciclib and elacestrant combination Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast... |
| 16.12.2022 | CMR Surgical enters into collaboration with Ethicon | CMR Surgical enters into collaboration with Ethicon Business Weekly article CMR Surgical, a global surgical robotics business growing from Cambridge, has clinched a collaboration agreement with Ethicon, a New Jersey-rooted Johnson & Joh... |
| 15.12.2022 | 18 European techbio investors that founders should know | 18 European techbio investors that founders should know Meet the most active investors in the European techbio scene Sifted article | By Clara Rodriguez Fernndez European VCs are investing more and more in the techbio space — startups at th... |
| 14.12.2022 | STORM Therapeutics announces closing of USD $30M Series B financing | STORM Therapeutics announces closing of USD $30M Series B financing Proceeds will advance STORM’s potential first-in-class clinical program targeting METTL3 for treatment of solid tumors and leukemias Financing will further expand STORM’s n... |
| 14.12.2022 | Sensible approach pays for Pragmatic | Sensible approach pays for Pragmatic The Times article | By Katie Prescott, Technology Business Editor A Cambridge-based semiconductor business has shrugged off the economic downturn and raised $35 million more than it had planned after see... |
| 13.12.2022 | Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House | Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House Versius has been introduced at Frances Perry House, a private women’s hospital in Melbourne to offer patients access to the benefits of robotic surge... |
| 13.12.2022 | Outlook 2023: The Pharma rollercoaster shows no signs of slowing down | Outlook 2023: The Pharma rollercoaster shows no signs of slowing down In Vivo article | By Joe Shorthouse Executive Summary What will 2023 bring as the industry faces one of the toughest periods in the last decade? In Vivo asked three indus... |
| 08.12.2022 | Innovate Cambridge gets Arm and Microsoft support to boost tech ecosystem | Innovate Cambridge gets Arm and Microsoft support to boost tech ecosystem UKTN article | By George Simister An initiative looking to promote innovation in the Cambridge tech ecosystem has received over 100 charter signatures from the likes ... |
| 08.12.2022 | AstraZeneca and Microsoft join steering committee as Innovate Cambridge initiative gains momentum | AstraZeneca and Microsoft join steering committee as Innovate Cambridge initiative to support, promote and enhance the Cambridge Innovation ecosystem on the global stage gains momentum 100 initial signatories join Cambridge Enterprise, Camb... |
| 07.12.2022 | New cohort underlines Cambridge’s role as DeepTech capital of Europe | New cohort underlines Cambridge’s role as DeepTech capital of Europe Business Weekly article | By Tony Quested Cambridge has this week taken further strides as the DeepTech capital of Europe. The continent’s ‘hottest’ accelerator, Deeptech ... |
| 06.12.2022 | Congenica awarded European contract to develop NGS analysis workflow in oncology | Congenica awarded European contract to develop NGS analysis workflow in oncology Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has been awarded the second stage of a contrac... |
| 02.12.2022 | Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment | Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment Endpoints article | by Katherine Lewin In a big week for Carrick Therapeutics, the company announced $60 million in funding for its lead breast cancer drug and dev... |
| 23.11.2022 | CIC news November 2022 | A warm welcome to our latest CIC newsletter. This edition covers an exciting period for CIC. We are delighted to share news of four new investments, our 2022 Impact and ESG report, continued team expansion and the launch of the Innovate Cam... |
| 23.11.2022 | STORM Therapeutics doses first patient with oral METTL3 targeting drug in a solid tumor Phase 1 study | STORM Therapeutics doses first patient with oral METTL3 targeting drug in a solid tumor Phase 1 study STC-15 is the first molecule specifically targeting an RNA methyltransferase to enter clinical development STORM Therapeutics Ltd. (STORM)... |
| 17.11.2022 | CMR Surgical announces more than 100 Versius systems installed globally | CMR Surgical announces more than 100 Versius systems installed globally CMR is delivering on its commercial strategy of rapid global expansion with systems installed across the world and more than 5,000 clinical cases performed CMR Surgical... |
| 17.11.2022 | Quantum computing moves from the theoretical to local startups | Quantum computing moves from the theoretical to local startups Just over 40 years after the field of quantum computing began, funding is on the rise locally for the hard-to-explain concept that has huge implications for businesses. Boston G... |
| 16.11.2022 | Riverlane opens US headquarters in Cambridge, MA | Riverlane opens US headquarters in Cambridge, MA Riverlane news | By Stefan Cap Riverlane, the world’s first quantum engineering company, has opened its US headquarter in Cambridge, Massachusetts across the Charles River from Boston in Kend... |
| 15.11.2022 | CIC invests in Cambridge GaN Devices $19m Series B round to tackle the $50B Global Power Semiconductor Market | Cambridge Innovation Capital invests in Cambridge GaN Devices $19m Series B round to tackle the $50B Global Power Semiconductor Market Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life science bus... |
| 15.11.2022 | Easy-to-use, Rugged ICeGaN GaN HEMTs From CGD now available in high volume | Easy-to-use, Rugged ICeGaN GaN HEMTs From CGD now available in high volume Monolithic SMART GaN HEMTs “drive like silicon“; reduce BOM count; deliver class-leading reliability performance Cambridge GaN Devices (CGD), the fabless, clean-tech... |
| 14.11.2022 | Riverlane unveils breakthrough in quantum error correction | Riverlane unveils breakthrough in quantum error correction World’s first scalable quantum error decoder is a critical component in the first generation of error corrected quantum computers Error correction is quantum computing’s defining ch... |
| 08.11.2022 | Bicycle Therapeutics announces first patient dosed in BT8009 Phase II expansion cohorts and provides program update | Bicycle Therapeutics announces first patient dosed in BT8009 Phase II expansion cohorts and provides program update The Phase II multi-center, open label trial will evaluate BT8009 administered at the recommended Phase II doses of 5mg/m2 an... |
| 07.11.2022 | Microbiotica — unlocking the microbiome as a multi-therapeutic modality | Microbiotica — unlocking the microbiome as a multi-therapeutic modality Microbiotica’s platform makes it a leader in precision clinical discovery of novel microbiome-based therapeutics and biomarkers. With the platform validated at scale, a... |
| 03.11.2022 | Bicycle Therapeutics reports third quarter 2022 financial results and provides corporate update | Bicycle Therapeutics reports third quarter 2022 financial results and provides corporate update Continued clinical progress across pipeline including BT5528 end of Phase I dose escalation update; completion of enrollment in BT5528 initial d... |
| 28.10.2022 | Gary Brotman: from the music industry to machine learning | Gary Brotman: from the music industry to machine learning AI & Machine Learning article | By Marcus Law Secondmind CEO Gary Brotman speaks to Technology Magazine about parallels between the music industry and AI, and being inspired by m... |
| 25.10.2022 | UK needs stronger regional innovation clusters outside South East | UK needs stronger regional innovation clusters outside South East Venture capital fund managers speak to Computer Weekly about the importance of innovation clusters to the UK tech ecosystem, and the need to develop further investment opport... |
| 21.10.2022 | AudioTelligence’s Aiso™ for hearing software wins Innovator Award | AudioTelligence’s Aiso™ for hearing software wins Innovator Award Today Cambridge startup AudioTelligence announces that its groundbreaking aiso™ for Hearing technology has won a Hearing Technology Innovator Award™. The company’s software r... |
| 20.10.2022 | STORM Therapeutics to present new data on its lead program STC-15 | STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule ther... |
| 20.10.2022 | DeepTech companies offered route across ‘Valley of Death’ | DeepTech companies offered route across ‘Valley of Death’ Business Weekly article A Cambridge initiative is set to help a new tranche of DeepTech startups across the so-called ‘Valley of Death’ so they make it safely from seed funding to Se... |
| 19.10.2022 | Inv€$tival Showcase | Inv€$tival Showcase CONNECTING LIFE SCIENCE & HEALTHCARE EXECUTIVES WITH CAPITAL & PARTNERS Part of Europe's biggest dedicated healthcare investment week Monday 14 November 2022 | Old Billingsgate, London, UK Join Cambridge Innovati... |
| 19.10.2022 | Q&A: BVCA’s VC committee chair on the current outlook for venture capital | Q&A: BVCA’s VC committee chair on the current outlook for venture capital Unquote article | By Ero Partsakoulaki Andrew Williamson, chair of the British Private Equity & Venture Capital Association’s (BVCA) venture capital committee... |
| 14.10.2022 | PragmatIC Semiconductor leads £2.4 million project to develop sustainable manufacturing technologies | PragmatIC Semiconductor leads £2.4 million project to develop sustainable manufacturing technologies Accelerates innovation in smart sustainable manufacturing technologies PragmatIC Semiconductor, a world leader in flexible electronics, tod... |
| 05.10.2022 | Sense and Abacus dx agree to distribute rapid, instrument-free molecular COVID-19 test in Australia and New Zealand | Sense and Abacus dx agree to distribute rapid, instrument-free molecular COVID-19 test in Australia and New Zealand Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement ... |
| 03.10.2022 | The path to useful quantum computers with error correction | The path to useful quantum computers with error correction Riverlane article By Jake Taylor, Chief Science Officer | Kenton Barnes, Senior Quantum Engineer | Rossy Nguyen, Senior Product Manager (Quantum Error Correction) Quantum computing ... |
| 29.09.2022 | Cambridge is UK’s top city for start-ups eyeing 2023 launch | Cambridge is UK’s top city for start-ups eyeing 2023 launch Business Weekly article New research from Virgin Money forecasts that Cambridge will be the best city in the UK to start a business in 2023. It beats, in order of priority in the t... |
| 28.09.2022 | Abcodia and its ovarian cancer test acquired by Oxford company | Abcodia and its ovarian cancer test acquired by Oxford company Business Weekly article | By Tony Quested Oxford-based GENinCode plc, which is quoted on AIM, has acquired Cambridge’s ovarian cancer company Abcodia for a maximum £1 million. T... |
| 26.09.2022 | First patients in Wales treated with Versius as part of national programme | First patients in Wales treated with Versius as part of national programme The first cases have taken place with Versius within the colorectal specialty at Cardiff & Vale University Health Board Betsi Cadwaladr University Health Board b... |
| 23.09.2022 | Riverlane publishes landmark paper towards useful, scalable quantum computing | Riverlane publishes landmark paper towards useful, scalable quantum computing Riverlane article | By Luka Skoric, Quantum Engineer In our recent work, Riverlane solved a long-standing quantum error correction problem, paving the way for sca... |
| 21.09.2022 | Versius installed at Institut Curie as part of research partnership | Versius installed at Institut Curie as part of research partnership CMR Surgical has signed a two-year clinical study partnership contract with Institut Curie, France’s leading cancer research centre, and ranked among the best cancer treatm... |
| 20.09.2022 | Cambridge Enterprise, CIC and the University of Cambridge launch ambitious ‘Innovate Cambridge’ initiative | Cambridge Enterprise, Cambridge Innovation Capital, and the University of Cambridge launch ambitious ‘Innovate Cambridge’ initiative Aims to define the future of the Greater Cambridge life sciences and technology ecosystem over the next dec... |
| 19.09.2022 | Bicycle announces publication of article highlighting preclinical data from BT8009 program in molecular cancer therapeutics | Bicycle Therapeutics announces publication of article highlighting preclinical data from BT8009 program in molecular cancer therapeutics Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated cla... |
| 17.09.2022 | OBN Awards 2022 | 18:30-23:30 | Venue: Royal Lancaster London The OBN Awards, now in their 14th year, are a highly regarded and sought-after awards programme for the Life Sciences industry, designed to celebrate innovation and outstanding achievement acros... |
| 13.09.2022 | Cambridge Innovation Capital Invests in Unlikely AI’s $20m Seed Round to Take Fresh Approach to AI | Cambridge Innovation Capital Invests in Unlikely AI’s $20m Seed Round to Take Fresh Approach to AI Cambridge Innovation Capital (CIC), the deeptech and life science venture investor focussed on companies connected with the Cambridge (UK) ec... |
| 12.09.2022 | Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022 | Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022 STORM recognised as an innovative early-stage biotechnology company pioneering novel drug targets STORM Therapeutics Ltd. (STORM), the biotechnology... |
| 12.09.2022 | Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies | Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies Company to leverage expertise in mitochondrial biology to advance novel treatments for both rare and common diseases Pretzel founded by l... |
| 09.09.2022 | Bicycle Therapeutics puts Life Sciences in the vanguard as Business of the Year | Bicycle Therapeutics puts Life Sciences in the vanguard as Business of the Year Business Weekly article Life sciences pioneer Bicycle Therapeutics was last night named as champion company at the Business Weekly Awards at Queens’ College in ... |
| 09.09.2022 | Bicycle Therapeutics, PragmatIC, Microbiotica all winners at the Business Weekly Awards | Bicycle Therapeutics puts Life Sciences in the vanguard as Business of the Year Business Weekly article Life sciences pioneer Bicycle Therapeutics was last night named as champion company at the Business Weekly Awards at Queens’ College in ... |
| 01.09.2022 | Sense and TECOmedical Sign Distribution Agreement for Germany, Austria, Switzerland | Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Sense’s Veros COVID-19, the first test on the rapid, instru... |
| 29.08.2022 | Scaling A Deep Tech Startup: Lessons From The Front Line | Scaling A Deep Tech Startup: Lessons From The Front Line Forbes.com article | Scott White CEO of PragmatIC Semiconductor, Scott White is an experienced serial entrepreneur leading his sixth technology venture at PragmatIC. A deep tech compa... |
| 22.08.2022 | Benchmarking: a quantum-computing building block | Benchmarking: a quantum-computing building block River Lane blog | By Luigi Martiradonna, Business Development Manager & Andrea Husseiniova, Associate Product Manager However promising, today’s quantum computers are nevertheless still ... |
| 16.08.2022 | CMR Surgical strengthens surgical training with new tele-mentoring offering | CMR Surgical strengthens surgical training with new tele-mentoring offering CMR Surgical partners with Teladoc Health and SurgEase Innovations to provide remote-case support during state-of-the-art surgical training and cases Virtual suppor... |
| 15.08.2022 | Seldon wins two Stevie® Awards | Seldon wins two Stevie® Awards We’re thrilled to announce that Seldon has won the Silver award for Artificial Intelligence/Machine Learning Solution and the Bronze award for Small Computer Software Company of the Year at the world’s premier... |
Show more
Mentions in press and media 86
| Date | Title | Description |
| 24.06.2026 | TRIMTECH Therapeutics Raises $47 Million Seed Funding To Advance Targeted Protein Degradation Portfolio | TRIMTECH Therapeutics announced that it has raised an additional $14 million in seed funding, bringing the total round to $47 million. The additional financing was led by Johnson & Johnson’s corporate venture capital organization, Johns... |
| 23.06.2026 | Trimtech Therapeutics Raises Additional $14M in Seed Funding | Trimtech Therapeutics, a Cambridge, UK-based biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, raised additional $14M in Seed funding. Back... |
| 22.05.2026 | Cambridge Wide Open Week 2026 announces top-tier keynotes & participating ventures for new expanded format | Cambridge Wide Open Week 2026 has unveiled further details of its highly anticipated June 11–19 event as the life sciences festival expands across the UK’s innovation “Golden Triangle” for the very first time. Keynote speakers for the event... |
| 19.05.2026 | Lansdowne Partners Ignites UK Innovation with New $150M VC Fund | Lansdowne Partners launched a pivotal new venture capital fund. It targets high-potential UK innovation. The fund secured $150 million in its initial close. It aims to bridge critical funding gaps. UK companies emerging from university rese... |
| 14.05.2026 | Lansdowne Partners: $150 Million First Close Announced For UK Innovation-Focused VC Fund | Lansdowne Partners has launched a venture capital fund focused on supporting high-potential UK companies emerging from the country’s university research base and startup ecosystem. The fund announced a first close of $150 million and is tar... |
| 14.05.2026 | Lansdowne Partners launches VC fund to scale UK innovation to global commercial success | Lansdowne Partners has launched a venture capital fund focused on backing high potential UK companies emerging from the country’s world class university research base and start up ecosystem. The fund announces a first close of $150 million ... |
| 26.02.2026 | BeyondMath Secures $18.5M for Generative Physics AI Expansion | BeyondMath, a DeepTech leader, secured $18.5M in seed funding. This includes a $10M extension round. The company pioneers generative physics AI. It delivers engineering simulations 1000 times faster. This redefines design across aerospace, ... |
| 25.02.2026 | BeyondMath secures $18.5M to expand its foundational physics AI model | London-based BeyondMath, a deeptech company that has developed a novel generative physics model, has raised a $10 million seed extension led by Cambridge Innovation Capital, with participation from existing investors including UP.Partners, ... |
| 02.12.2025 | TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board | Cambridge, UK, 2 December 2025: TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced the appointment ... |
| 18.11.2025 | T-Therapeutics Secures $91 Million to Advance Bispecific Therapies | T-Therapeutics boosts Series A to $91M. New funds will push cancer, autoimmune bispecifics to trials. OpTiMus platform aims to unlock undruggable targets. Investors show strong confidence. **T-Therapeutics Secures $91 Million to Advance Bis... |
| 14.11.2025 | T-Therapeutics: Series A Extended To $91 Million As It Advances First-In-Class Bispecifics Toward The Clinic | T-Therapeutics has expanded its Series A financing to a total of $91 million after securing an additional $32 million from new and existing investors. The Cambridge-based biotechnology company, which develops next-generation T cell receptor... |
| 01.08.2025 | VC firm Cambridge Innovation Capital commits €115 million to back University of Cambridge spinouts | Cambridge Innovation Capital (CIC), the VC firm investing in British high-potential DeepTech and life sciences companies, announced they are committing at least €115 million to invest in spinouts from the University of Cambridge. This inves... |
| 28.05.2025 | BGF’s £3bn pledge offers hope amid concerns over UK competitiveness | The Business Growth Fund (BGF) has unveiled a £3bn commitment to back British businesses over the next five years which includes £500m earmarked for early stage start-ups in deep tech and life sciences. The organisation, which is one of the... |
| 09.05.2025 | Deliveroo’s sale reignites fear over UK’s tech exodus | When London-headquartered Deliveroo announced in early May that it had agreed to be acquired by US delivery giant Doordash, it triggered more than just a major shakeup in the food tech sector. To many in the industry, it was a familiar stor... |
| 03.05.2025 | Cambridge GaN Devices – Closes $32m Series C funding round | We are pleased to announce our latest investment in Cambridge GaN Devices (CGD), a University of Cambridge spinout developing energy-efficient semiconductors using gallium nitride (GaN), reshaping the future of power electronics. CGD’s tech... |
| 10.03.2025 | Cambridge Innovation Capital: £100 Million Opportunity Fund Closed | Cambridge Innovation Capital (CIC), a leading venture capital firm embedded in the Cambridge ecosystem, announced it has launched a new £100 million Opportunity Fund – which is anchored by Aviva Investors and British Patient Capital – to in... |
| 07.03.2025 | TRIMTECH Therapeutics: A New Dawn in Neurodegenerative Disease Treatment | In the heart of Cambridge, a biotech revolution is brewing. TRIMTECH Therapeutics has emerged as a beacon of hope for those grappling with neurodegenerative diseases. With a recent funding boost of €28.6 million, the company is poised to ta... |
| 06.03.2025 | TRIMTECH Therapeutics raises €28.6 million for treatment of neurodegenerative diseases | Cambridge-based TRIMTECH Therapeutics, a BioTech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, announced the closing of its €28.6 million Seed funding round. The financing was led by ... |
| 05.03.2025 | TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases | Cambridge, UK, 05 March 2025: TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, today announced the closing of its $31 million (£25 million) seed funding ... |
| 24.02.2025 | Cambridge GaN Devices: $32 Million (Series C) Raised For Energy-Efficient Semiconductors | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, announced it closed a $32 million Series C funding round. The funding round was led by a strategic investor with participation from British Patient Capital an... |
| 24.02.2025 | Cambridge Innovation Capital launches £100M Fund for deeptech and life sciences | Cambridge Innovation Capital (CIC) has today launched a new £100 million Opportunity Fund to invest in growth stage deep tech and life sciences companies. With up to £20 million per investment into later-stage rounds of deep tech and life s... |
| 24.02.2025 | Cambridge Innovation Capital launches £100m Opportunity Fund | Aviva Investors and British Patient Capital lead investment into new growth fund addressing the UK’s scale-up funding gap. 24 February 2025, Cambridge, UK — Cambridge Innovation Capital (CIC), the leading venture capital firm embedded in th... |
| 19.02.2025 | Cambridge GaN Devices Secures $32M to Power Global Expansion | In a world racing towards energy efficiency, Cambridge GaN Devices (CGD) has emerged as a beacon of innovation. The UK-based company recently secured $32 million in Series C funding, a financial boost that promises to accelerate its growth ... |
| 18.02.2025 | Cambridge GaN Devices secures €30.5 million to drive global growth in power semiconductor industry | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, has successfully closed a €30.5 million Series C funding round to expand globally and deliver its products to high-power industrial, data centre, and automoti... |
| 24.10.2024 | Epitopea Closes USD $31M Pre-Series A Financing | Epitopea, a Cambridge, UK- and Montreal, Canada-based cancer immunotherapeutics company, raised USD $31M in Pre-Series A funding. Backers included Investissement Québec, adMare BioInnovations, Jonathan Milner, existing investors Advent Life... |
| 24.10.2024 | Innovate Cambridge launches strategy to accelerate innovation through increased startup investment | Cambridge, UK has unveiled a plan to supercharge the impact of the Greater Cambridge area by doubling the rate at which it builds unicorns, doubling the venture capital investment the city’s startups receive, and creating twice as many scie... |
| 22.10.2024 | Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression | Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, announced it had completed a $75 million financing round (circa £57 million). The funding round was led by El... |
| 17.10.2024 | Nuclera's $75 Million Leap: A New Era for Protein Discovery | In the world of biotechnology, speed is everything. Nuclera, a Cambridge-based biotech company, has just secured a $75 million Series C funding round. This significant investment is a game-changer, pushing the boundaries of protein discover... |
| 16.10.2024 | Nuclera raises $75M Series C for eProtein discovery system | Biotech Nuclera has raised a $75 million Series C financing round. This brings the company’s funding to over $140 million. The company is accelerating protein expression and purification workflows through its benchtop protein system, eProte... |
| 16.08.2024 | Riverlane: Quantum Error Correction Company Secures $75 Million (Series C) | Riverlane, the global leader in quantum error correction technology, announced that it has raised $75 million in Series C funding to deliver its groundbreaking quantum error correction (QEC) roadmap. The funding will enable Riverlane to exp... |
| 07.08.2024 | Riverlane's Quantum Leap: $75 Million Series C Funding to Revolutionize Quantum Computing | In the heart of Cambridge, a revolution is brewing. Riverlane, a pioneer in quantum error correction technology, has secured $75 million in Series C funding. This investment is not just a financial boost; it’s a ticket to the future of quan... |
| 06.08.2024 | Riverlane raises $75M Series C for quantum error correction technology | Quantum error correction tech company Riverlane has raised $75 million in Series C funding, bringing their funding to over $122 million. Planet First Partners led the round, with participation from ETF Partners, EDBI, Cambridge Innovation C... |
| 06.08.2024 | Cambridge-based Riverlane nabs €68.6 million Series C to deliver quantum error correction roadmap | Riverlane, a global leader in quantum error correction technology, announced that it has raised €68.6 million in Series C funding to deliver its groundbreaking quantum error correction (QEC) roadmap. The round was led by Planet First Partne... |
| 06.08.2024 | Riverlane raises $75 million to meet surging global demand for quantum error correction technology | Cambridge, UK; Boston, US: Riverlane, the global leader in quantum error correction technology, announces that it has raised $75 million in Series C funding to deliver its groundbreaking quantum error correction (QEC) roadmap. The funding w... |
| 16.11.2023 | Cambridge Innovation Capital announces its investment in T-Therapeutics’ £48 Million Series A Funding | Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in T-Therapeutics’ £48 Million Series A funding round alongside leading European and ... |
| 18.10.2023 | 5 investors on the pros and cons of open source AI business models | As the generative AI boom continues, startups building business models around the tech are beginning to delineate along two clear lines. Some, convinced that a proprietary and closed source approach will give them an advantage over the swar... |
| 22.09.2023 | CMR Surgical raises $165M for robotic-aided minimal access surgery | This week, surgical robotics business CMR Surgical announced that it closed an upsized $165 million fundraising round. CMR’s vision is to make minimal access surgery (MAS) universally accessible, rapidly increasing the number of robotic-ass... |
| 17.04.2023 | Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding | Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has ... |
| 04.04.2023 | Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding | Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in ... |
| 30.03.2023 | Innovation and technology clusters or the Premier League? - The economic impact of the University of Cambridge | When discussing learning outcomes and different contributions of various Universities, there is one very important aspect that needs to be analysed and taken into account when talking about the importance and quality of higher education – t... |
| 09.11.2022 | Meta acquires Audio Analytic | Meta has reportedly acquired Cambridge-based sound recognition developer Audio Analytic in a deal that will inevitably be seen as reviving momentum following a dreary third quarter for the social media, ads and metaverse giant (here's The T... |
| 20.09.2022 | Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies | What You Should Know: Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondri... |
| 13.09.2022 | Cambridge Innovation Capital Invests in Unlikely AI’s $20m Seed Round to Take Fresh Approach to AI | Cambridge Innovation Capital Invests in Unlikely AI’s $20m Seed Round to Take Fresh Approach to AI Cambridge Innovation Capital (CIC), the deeptech and life science venture investor focussed on companies connected with the Cambridge (UK) ec... |
| 12.05.2022 | Meet Salience Labs: The Oxford startup that chipped in $11.5 million to develop high-speed chips for AI applications | The speed of AI computation doubles every 3.4 months, outpacing what standard semiconductor technologies have left to offer. Meanwhile, AI hardware is moving away from general purpose applications in response to market demands which are inc... |
| 26.04.2022 | Cambridge Innovation Capital raises USD 300 million in FUND II | UK-based Cambridge Innovation Capital (CIC), a venture capital firm backing life sciences and technology companies, raised USD 300 million (£225 million) in Fund II. The round took place on April 25, 2022. Investors in Fund II include a geo... |
| 26.04.2022 | Elon Musk is buying Twitter. Here’s what comes next | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Goodbye, TWTR ticker. Hello to the reign of the world’s wealthiest man, Elon Musk. While Musk tak... |
| 25.04.2022 | Cambridge Innovation Capital is going the distance with its second fund at £225 million | Backing deeptech and life sciences startups with a connection to the Cambridge ecosystem, Cambridge Innovation Capital has reloaded the cannons and raised £225 million for its oversubscribed second fund. Through this raise CIC now has over ... |
| 25.04.2022 | Advancing cancer treatments, medtech startup Epitopea raises £10.3 million | Cambridge-based Epitopea has raised £10.3 million in a seed funding round. The medtech startup is developing off-the-shelf cancer immunotherapies designed to treat a broad patient population. The influx of capital will be used to further ad... |
| 25.04.2022 | Cambridge Innovation Capital closes €267M Fund II to support its portfolio companies | Cambridge Innovation Capital, a VC that backs life sciences and technology companies connected with the Cambridge ecosystem, announced on Monday that it has raised £225M (approximately €267M) for its oversubscribed Fund II. Half of the capi... |
| 07.03.2022 | Tencent backs Cambridge-based startup in $67 million funding to address opportunities in biomedicine | Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microbiotica has raised £50 million ($67 million) funding. The Series B round was co-led by Flerie Invest and Tencent with participation from new ... |
| 18.10.2021 | PragmatIC Semiconductor secures $80 million funding | PragmatIC Semiconductor secures $80 million funding New investment supports second FlexLogIC fab to meet soaring demand for flexible chips PragmatIC Semiconductor, a world leader in flexible electronics, is proud to announce that it has sec... |
| 08.09.2021 | PetMedix raises $37M Series B | PetMedix raises $37M Series B “PetMedix has a global vision: elevating expectations in pet care the world over. This financing round not only provides the capital required to take us to the next level, but also the international perspective... |
| 17.06.2021 | There’s a new accelerator on the block, meet Cambridge’s Deeptech Labs | When the words deep tech and the University of Cambridge end up in the same sentence, chances are there’s going to be a pretty good show. And as it would appear, newly launched Deeptech Labs has been fine-tuning the orchestra. Based in, you... |
| 17.06.2021 | Origami raises £20 million in Series C funding round led by Barclays | Origami raises £20 million in Series C funding round led by Barclays 17-06-2021 Cambridge based Origami has raised £20.5m of new funding to help drive its next phase of growth. Barclays PLC led the round, investing as part of their Sustaina... |
| 16.06.2021 | Through The Valley—Cambridge Accelerator Steers Deeptech Startups ‘From Seed To Series A’ | Miles Kirby, CEO of Deeptech LabsPhotovibe |
| 14.06.2021 | New Cambridge accelerator for deeptech startups launches with five machine learning investments | New Cambridge accelerator for deeptech startups launches with five machine learning investments 14-06-2021 Deeptech Labs (DTL), a new post-seed accelerator aimed at deep technology (deeptech) start-ups, has been founded in Cambridge to brin... |
| 29.03.2021 | CIC participates in Gyroscope Therapeutics’ £107.8 million Series C financing | CIC participates in Gyroscope Therapeutics’ £107.8 million Series C financing 29-03-2021 Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life science businesses in the Cambridge ecosystem, is pleased... |
| 15.03.2021 | Cambridge/Bristol-based next gen positioning firm FocalPoint raises £6 million in Series B round | UK based deep-tech company FocalPoint has closed a Series-B round which saw a fresh £6 million line the coffers. The round was fully funded by Draper Esprit, and no further details were provided. This now brings FocalPoint’s total raised to... |
| 10.02.2021 | Commercializing deep tech startups: A practical guide for founders and investors | Vin Lingathoti Contributor Share on Twitter Vin Lingathoti is a partner at Cambridge Innovation Capital, where he focuses on technology investments. A software engineer by background, Vin has spent more than a decade in Silicon Valley worki... |
| 27.01.2021 | UK’s Riverlane raises €16.4M; here’s how it transforms quantum computers from experimental tech to commercial products | According to IBM, “Quantum computers can boost the development of new breakthroughs in science, medications to save lives, machine learning methods to diagnose illnesses sooner, materials to make more efficient devices and structures, finan... |
| 25.01.2021 | Riverlane secures $20 million in Series A funding | New funding will accelerate Riverlane’s mission to build a high-performance operating system that makes quantum computers useful, sooner. Riverlane has raised $20m in Series A funding to build Deltaflow, its operating system for quantum com... |
| 25.01.2021 | Riverlane secures $20 million in Series A funding | Riverlane secures $20 million in Series A funding 25-01-2021 New funding will accelerate Riverlane’s mission to build a high-performance operating system that makes quantum computers useful, sooner. Riverlane has raised $20m in Series A fun... |
| 15.12.2020 | Join CIC for its Deep Tech Series A office hours session | Join CIC for its Deep Tech Series A office hours session 15-12-2020 Here is a unique opportunity to get in front of one of the UK’s leading Deep Tech Series A investors and learn from them what a good Series A pitch looks like. The particip... |
| 18.11.2020 | Cambridge Innovation Capital leads £7.1 million Series A investment in Seldon | Cambridge Innovation Capital leads £7.1 million Series A investment in Seldon Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, is p... |
| 16.11.2020 | Start Codon closes new £15 million venture fund to translate life science innovation into successful companies | Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP at £15 million ($20 million USD). The Fund will be used to support Start Codon’s offering to st... |
| 16.11.2020 | Start Codon closes new £15 million venture fund to translate life science innovation into successful companies | Start Codon closes new £15 million venture fund to translate life science innovation into successful companies 16-11-2020 Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has cl... |
| 14.11.2020 | As COVID surges, what can data tell us about Airbnb’s recovery? | This is The TechCrunch Exchange, a newsletter that goes out on Saturdays, based on the column of the same name. You can sign up for the email here. DoorDash filed to go public on Friday, meaning we’ll have at least one more unicorn IPO befo... |
| 11.11.2020 | Malaysia’s Xeraya Capital invests in Congenica’s $50m Series C funding round | Premium Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid... |
| 11.11.2020 | Malaysia’s Xeraya Capital invests in Congenica’s $50m Series C funding round | Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid and acc... |
| 02.10.2020 | nChain co-leads the $5.4M Series A investment round in Geospock with Cambridge Innovation Capital | nChain Leads Investment Round in Extreme-scale Data Firm GeoSpock Article by the Financial Times nChain, a world-leading provider of enterprise-grade public blockchain solutions, today announces a lead investment in GeoSpock, the Cambridge-... |
| 02.10.2020 | GeoSpock announces additional $5.4 million in strategic investment | GeoSpock has announced $5.4m in additional funding to accelerate the development and adoption of the fastest, most scalable database on the market. This strategic investment round brings the total GeoSpock has raised to date to over $32 mil... |
| 02.10.2020 | GeoSpock announces additional $5.4 million in strategic investment | GeoSpock announces additional $5.4 million in strategic investment 02-10-2020 GeoSpock has announced $5.4m in additional funding to accelerate the development and adoption of the fastest, most scalable database on the market. This strategic... |
| 29.09.2020 | The Need For Speed—Is Quantum Computing A Good Space For Startups? | Andrew Williamson, managing partner at Cambridge Innovation CapitalTom Campbell www.tcampbell.co.uk +44(0)7813 103552 |
| 26.05.2020 | CIC portfolio company Inivata announces strategic collaboration and investment from NeoGenomics | CIC portfolio company Inivata announces strategic collaboration and investment from NeoGenomics 26-05-2020 Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in ... |
| 24.04.2020 | Inivata launches RaDaR™ for the detection of residual disease and recurrence | Inivata launches RaDaR™ for the detection of residual disease and recurrence 24-04-2020 Inivata, a Cambridge Innovation Capital portfolio company and a leader in liquid biopsy, announces the availability of RaDaR™, an assay for the detectio... |
| 02.12.2019 | Cambridge Innovation Capital attracts £1 billion of investment into Cambridge companies | Cambridge Innovation Capital attracts £1 billion of investment into Cambridge companies 02-12-2019 Since its foundation, Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies, highlighting its dominant... |
| 19.12.2018 | Morphogen-IX raises £18.4m in a Series B financing | Morphogen-IX raises £18.4m in a Series B financing 19-12-2018 Morphogen-IX Ltd, a University of Cambridge spin-out biotechnology company focused on the development of bone morphogenetic proteins (BMPs) for the treatment of pulmonary arteria... |
| 22.02.2018 | Cambridge Innovation Capital leads GeoSpock £5 million Series A funding | Cambridge Innovation Capital plc (CIC) has led a £5 million Series A funding round in GeoSpock. Japanese strategic investors Global Brain and 31 Ventures also invested in this round, alongside other existing investors. GeoSpock aims to beco... |
| 20.10.2016 | Undo raises $3.3 million in series A financing led by Cambridge Innovation Capital | Undo, the leading commercial supplier of next-generation software quality tools for Linux and Android developers, today announced it has closed a $3.3 million Series A financing round. The round was led by Cambridge Innovation Capital (CIC)... |
| 18.01.2016 | Morphogen-IX Raises £1.5M in Seed Funding | Morphogen-IX, a Cambridge, UK-based biotech company, raised £1.5m in seed funding. The round was led by Index Ventures, with participation from Cambridge Innovation Capital and Cambridge Enterprise Seed Funds. The company intends to use the... |
| 12.08.2014 | Cambridge Innovation Capital announces first three investments from its £50 million Cambridge Cluster fund | Cambridge Innovation Capital announces first three investments from its £50 million Cambridge Cluster fund Cambridge Innovation Capital (CIC), an investor in high-growth technology companies in the Cambridge cluster, has completed its first... |
| - | Cambridge Innovation Capital is going the distance with its second fund at £225 million | Backing deeptech and life sciences startups with a connection to the Cambridge ecosystem, Cambridge Innovation Capital has reloaded the cannons and raised £225 million for its oversubscribed second fund. Through this raise CIC now has over ... |
| - | There’s a new accelerator on the block, meet Cambridge’s Deeptech Labs | When the words deep tech and the University of Cambridge end up in the same sentence, chances are there’s going to be a pretty good show. And as it would appear, newly launched Deeptech Labs has been fine-tuning the orchestra. Based in, you... |
| - | Tencent backs Cambridge-based startup in $67 million funding to address opportunities in biomedicine | Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microbiotica has raised £50 million ($67 million) funding. The Series B round was co-led by Flerie Invest and Tencent with participation from new ... |
| - | Meet Salience Labs: The Oxford startup that chipped in $11.5 million to develop high-speed chips for AI applications | The speed of AI computation doubles every 3.4 months, outpacing what standard semiconductor technologies have left to offer. Meanwhile, AI hardware is moving away from general purpose applications in response to market demands which are inc... |
| - | Advancing cancer treatments, medtech startup Epitopea raises £10.3 million | Cambridge-based Epitopea has raised £10.3 million in a seed funding round. The medtech startup is developing off-the-shelf cancer immunotherapies designed to treat a broad patient population. The influx of capital will be used to further ad... |
Show more